Business Description
CVS Health Corp
NAICS : 621399
SIC : 8099
Compare
Compare
Traded in other countries / regions
CVS.AustriaCVSH34.BrazilCVS.CanadaCVS.ChileCVS.GermanyCVS.MexicoCVS.Peru0HRS.UKCVS.USA IPO Date
2019-04-25Description
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the U.S. CVS is also the largest pharmacy benefit manager (acquired through Caremark), processing over 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 24 million medical members. The company's pending acquisition of Oak Street will add primary care to the mix, which could have significant synergies with all its existing business lines.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.23 | |||||
| Equity-to-Asset | 0.3 | |||||
| Debt-to-Equity | 1.07 | |||||
| Debt-to-EBITDA | 6.35 | |||||
| Interest Coverage | 6.92 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.11 | |||||
| Beneish M-Score | -2.45 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.4 | |||||
| 3-Year EBITDA Growth Rate | -9.9 | |||||
| 3-Year EPS without NRI Growth Rate | -14.8 | |||||
| 3-Year FCF Growth Rate | 8.5 | |||||
| 3-Year Book Growth Rate | 3.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 5.9 | |||||
| Future 3-5Y Total Revenue Growth Rate | 5 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.52 | |||||
| 9-Day RSI | 36.77 | |||||
| 14-Day RSI | 37.48 | |||||
| 6-1 Month Momentum % | -32.2 | |||||
| 12-1 Month Momentum % | -28.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.92 | |||||
| Quick Ratio | 0.67 | |||||
| Cash Ratio | 0.24 | |||||
| Days Inventory | 24 | |||||
| Days Sales Outstanding | 13.93 | |||||
| Days Payable | 17.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.48 | |||||
| Dividend Payout Ratio | 0.75 | |||||
| 3-Year Dividend Growth Rate | 3.2 | |||||
| Forward Dividend Yield % | 3.47 | |||||
| 5-Year Yield-on-Cost % | 3.73 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 16.41 | |||||
| Operating Margin % | 4.79 | |||||
| Net Margin % | 1.2 | |||||
| ROE % | 5.49 | |||||
| ROA % | 1.71 | |||||
| ROIC % | 6.46 | |||||
| ROC (Joel Greenblatt) % | 25.3 | |||||
| ROCE % | 4.87 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 22.19 | |||||
| Forward PE Ratio | 7.89 | |||||
| PE Ratio without NRI | 22.32 | |||||
| Shiller PE Ratio | 12.97 | |||||
| Price-to-Owner-Earnings | 5.68 | |||||
| PEG Ratio | 7.44 | |||||
| PS Ratio | 0.27 | |||||
| PB Ratio | 1.2 | |||||
| Price-to-Free-Cash-Flow | 5.05 | |||||
| Price-to-Operating-Cash-Flow | 4.38 | |||||
| EV-to-EBIT | 17.99 | |||||
| EV-to-Forward-EBIT | 8.22 | |||||
| EV-to-EBITDA | 11.72 | |||||
| EV-to-Forward-EBITDA | 7.12 | |||||
| EV-to-Revenue | 0.43 | |||||
| EV-to-Forward-Revenue | 0.4 | |||||
| EV-to-FCF | 8.15 | |||||
| Price-to-Projected-FCF | 0.5 | |||||
| Price-to-DCF (Earnings Based) | 1.86 | |||||
| Price-to-DCF (FCF Based) | 0.23 | |||||
| Price-to-Median-PS-Value | 0.6 | |||||
| Earnings Yield (Greenblatt) % | 5.56 | |||||
| Forward Rate of Return (Yacktman) % | 18.99 |
Balance Sheet Breakdown
Cashflow Statement Breakdown
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
CVS Health Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 317,052.522 | ||
| EPS (TTM) (€) | 2.677 | ||
| Beta | 0.47 | ||
| Volatility % | 19.31 | ||
| 14-Day RSI | 37.48 | ||
| 14-Day ATR (€) | 0.809704 | ||
| 20-Day SMA (€) | 63.432 | ||
| 12-1 Month Momentum % | -28.21 | ||
| 52-Week Range (€) | 61.9 - 104.68 | ||
| Shares Outstanding (Mil) | 1,282.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CVS Health Corp Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
CVS Health Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
CVS Health Corp Frequently Asked Questions
What is CVS Health Corp(WBO:CVS)'s stock price today?
The current price of WBO:CVS is €62.30. The 52 week high of WBO:CVS is €104.68 and 52 week low is €61.90.
When is next earnings date of CVS Health Corp(WBO:CVS)?
The next earnings date of CVS Health Corp(WBO:CVS) is 2023-08-03 Est..
Does CVS Health Corp(WBO:CVS) pay dividends? If so, how much?
The Dividend Yield %  of CVS Health Corp(WBO:CVS) is 3.48% (As of Today), Highest Dividend Payout Ratio of CVS Health Corp(WBO:CVS) was 0.75. The lowest was 0.24. And the median was 0.34. The  Forward Dividend Yield % of CVS Health Corp(WBO:CVS) is 3.47%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
